Clinical Trial Update: Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates that the phase 1/2 study evaluating hypo-hyperfractionated chest radiation with Taxotere and Xeloda for non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Clinical Oncology Research Associates | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: WITHDRAWN